Načítá se...
Cardiovascular Safety of VEGF-Targeting Therapies: Current Evidence and Handling Strategies
Treatment with the angiogenesis inhibitors bevacizumab, sunitinib, and sorafenib as single agents or in combination with conventional chemotherapy is becoming a cornerstone of modern anticancer therapy. However, the potential toxicity of these drugs, mainly to the cardiovascular system, is still bei...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AlphaMed Press
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228010/ https://ncbi.nlm.nih.gov/pubmed/20547589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0235 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|